{"id":"W2115861091","doi":"10.1634/theoncologist.2010-0387","title":"Targeting Angiogenesis in Esophagogastric Adenocarcinoma","year":2011,"lang":"en","type":"review","venue":"The Oncologist","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"AstraZeneca; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Sorafenib; Bevacizumab; Sunitinib; Angiogenesis; Internal medicine; Receptor tyrosine kinase; Oncology; Cancer research; Cancer; Vascular endothelial growth factor; Chemotherapy; Receptor; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005987323,0.0003548479,0.001537489,0.0003474087,0.00006815703,0.00001852538,0.0004384455,0.0002131065,0.000372664],"category_scores_gemma":[0.0001355766,0.0002022429,0.0005127019,0.0008686887,0.0001303476,0.0000286644,0.0002393428,0.0003972817,0.000289693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004682519,"about_ca_system_score_gemma":0.0002685396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002700639,"about_ca_topic_score_gemma":0.00003137191,"domain_scores_codex":[0.9983022,0.0001648715,0.0005881553,0.0003623521,0.000167498,0.0004149121],"domain_scores_gemma":[0.9988654,0.0002043087,0.000334002,0.0005002501,0.00002525521,0.00007073688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002485842,0.00007804306,0.004680504,0.003816361,0.0001612257,0.0002761098,0.00005235932,4.885306e-7,2.946686e-8,0.0001990612,0.007929848,0.9827811],"study_design_scores_gemma":[0.000434891,0.0001651448,0.004590507,0.001377333,0.001775894,0.00006397818,0.00006152001,0.000001509279,7.627778e-8,0.00002333159,0.9913394,0.0001663866],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000244195,0.9917206,0.00001191716,0.000144897,0.000356757,0.001252336,0.000006795278,0.00006590025,0.006416342],"genre_scores_gemma":[0.000268213,0.9941111,0.0002255867,0.0001840612,0.0004699635,0.0001880426,0.00005541083,0.00004674275,0.004450832],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9834096,"threshold_uncertainty_score":0.8247225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1146690655374631,"score_gpt":0.361694059169733,"score_spread":0.2470249936322699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}